Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

29526
1
Inhibrx Biosciences, Inc. Inhibrx Biosciences Reports Significant Financial Changes, Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29527
1
Unusual Machines, Inc. Unusual Machines Reports Significant Revenue Growth, Increased Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29528
1
Oklo Inc. Oklo Inc. Reports Significant Financial Changes, Net Loss Increases in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

29529
1
FLYEXCLUSIVE INC. flyExclusive Reports 24% Revenue Growth, Widened Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29530
1
Bionano Genomics, Inc. Bionano Genomics Reports Significant Financial Decline, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29531
1
Lakeside Holding Ltd Lakeside Holding Reports Mixed Financial Results, Net Loss, and Increased Cash Reserves

Via official filing (AI summary) | over 1 year ago | 0 comments

29532
1
AMAZE HOLDINGS, INC. Fresh Vine Wine Reports Significant Financial Challenges, Revenue Decline, and Worsening Deficit in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29533
1
GENELUX Corp Genelux Corporation Reports Mixed Financial Results, Focuses on Research and Development

Via official filing (AI summary) | over 1 year ago | 0 comments

29534
1
NRX Pharmaceuticals, Inc. NRX Pharmaceuticals Reports Improved Financials, Advances Lead Drug Candidates

Via official filing (AI summary) | over 1 year ago | 0 comments

29535
1
Dror Ortho-Design, Inc. Dror Ortho-Design Reports Significant Financial Challenges, Raises Doubts About Its Ability to Continue as a Going Concern

Via official filing (AI summary) | over 1 year ago | 0 comments

29536
1
Dare Bioscience, Inc. Daré Bioscience Reports Significant Financial Decline and Turnaround in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

29537
1
Mobiquity Technologies, Inc. Mobiquity Technologies Reports 219% Revenue Growth in Q3 2024, Despite Ongoing Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

29538
1
LIQTECH INTERNATIONAL INC LiqTech International Reports Significant Financial Challenges, Decline in Revenue and Gross Profit

Via official filing (AI summary) | over 1 year ago | 0 comments

29539
1
Vado Corp. Vado Corp. Reports 17.4% Revenue Growth, Net Operating Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29540
1
PLUS THERAPEUTICS, INC. Plus Therapeutics Reports Revenue Growth, Net Loss, and Cash Flow Concerns in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29541
1
NOCERA, INC. Nocera, Inc. Reports Significant Decline in Net Sales and Net Loss in Q3 2024, Despite Gross Profit Increase

Via official filing (AI summary) | over 1 year ago | 0 comments

29542
1
HealthLynked Corp HealthLynked Corp. Reports Significant Financial Challenges, Decline in Revenue and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

29543
1
DURECT CORP DURECT Corporation Reports Q3 2024 Financial Results, Revenue Growth Offset by Net Loss and Liquidity Concerns

Via official filing (AI summary) | over 1 year ago | 0 comments

29544
1
GHST World Inc. GHST World Inc. Reports Improved Financials, But Remains Concerned About Future Viability

Via official filing (AI summary) | over 1 year ago | 0 comments

29545
1
NATURAL GAS SERVICES GROUP INC Natural Gas Services Group Reports 29.7% Revenue Growth in Q3 2024, 36.7% for Nine-Month Period

Via official filing (AI summary) | over 1 year ago | 0 comments

29546
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports Significant Financial Challenges, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29547
1
Owlet, Inc. Owlet, Inc. Reports 140.9% Revenue Growth, Improved Gross Margin in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29548
1
TruGolf Holdings, Inc. TruGolf Holdings Reports 81.74% Revenue Growth, Narrowed Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

29549
1
Onfolio Holdings, Inc Onfolio Holdings Reports 53% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

29550
1
Airship AI Holdings, Inc. Airship AI Holdings Reports Significant Revenue Growth and Improved Net Income in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments